Cite
HARVARD Citation
Xu, B. et al. (2022). Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4. European journal of cancer. pp. 236-245. [Online].